Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
about
Cannabinoids in health and diseaseThe endocannabinoid system as an emerging target of pharmacotherapyModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionEarly Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritisCannabidiol is an allosteric modulator at mu- and delta-opioid receptorsMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideCannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbancesThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisFluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human CognitionCannabidiol: an overview of some pharmacological aspects.Effects of cannabidiol (CBD) on regional cerebral blood flow.Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the EvidenceBlunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.Neuroanatomical substrates involved in cannabinoid modulation of defensive responses.High times for cannabis: Epigenetic imprint and its legacy on brain and behavior.The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan MetabolismCannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.Antiaversive effects of cannabinoids: is the periaqueductal gray involved?A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats.Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
P2860
Q24633884-58F494C5-3F85-4325-ABBF-CAC2FA169F25Q24648473-89B7D5D3-AAC4-44A3-82A1-624F20DC4FE9Q27014154-9DB1EC90-8671-4769-8857-2ADAF6B4114DQ27336497-3DFBD465-8542-4B46-B1AE-99DF0BB12409Q28250612-615202E5-DB71-48EF-82B2-13DF38B679DDQ28298326-55E498D5-D57C-4033-AD83-DAE49360A9E8Q28362078-926F4CBD-6BF7-4D41-A531-2A670F44C2B1Q28576747-6C4CC4EA-2445-4CD2-B8A4-0FA0E5A38273Q30047193-CB858FDF-2EA6-40B5-96E4-60BA993A58B1Q30376980-684B1326-3774-4E01-B357-543A4FA83949Q30473707-22E265EF-A984-41D7-894B-9B98E0408749Q33700887-F41BD6CB-2E78-4A12-B889-2C4B2B67E918Q34157378-5C4F3840-7101-4B78-BFE7-760A068A7DC9Q34272906-823F164A-70BF-41FF-87E2-DBD29817972EQ34446887-8A4C93BB-021A-4207-9F8A-7EAD011F5FAEQ34669534-814C6050-2114-401A-963D-27F80DD03F9AQ34849183-A3D04263-8A39-4E55-8F93-60FD72A4316EQ35647941-6DB6303B-D498-4CFE-B316-8951D410E41BQ37237991-1CD28EE5-DA4C-4ABE-A540-7942B432D9ABQ37880502-7D8271FB-10DB-43B2-A277-DFD3A9ADB866Q38784874-DFB88400-FE4E-4AFB-AB12-6F6DD26B9ACFQ38974424-CD2DF4F5-E146-4293-8181-304A1C569D97Q39166556-0C5D09FE-EA84-4CBD-90AB-534AB65B9193Q41351855-FB92D40D-E6FD-408B-ABDB-EB24F8B0F0D5Q42635065-28B579FA-CC48-40FE-A564-46AF07A85B0EQ50715525-F4C62DBF-CF2D-4A48-8433-B917170A8C0DQ57300019-943CC82A-0863-4C9C-9CB5-6FE5D5B1E57B
P2860
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@en
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@nl
type
label
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@en
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@nl
prefLabel
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@en
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@nl
P2093
P921
P1433
P1476
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
@en
P2093
Guimarães FS
de Aguiar JC
P304
P356
10.1016/0306-3623(94)90027-2
P577
1994-01-01T00:00:00Z